Unternehmensführung

Führungsebene

Unser interkulturelles Executive-Team besteht aus Experten aus Medizin und Technologie, die für Glooko medizinische Innovation und wirtschaftlichen Erfolg in Einklang bringen

Russ Johannesson

Chief Executive Officer

clements

Mark Clements, M.D., Ph.D.

Chief Medical Officer

Stephen Lien

Chief Financial Officer

Prakash Menon

Chief Technology Officer

David Conn

Executive Vice President of Partnerships & Alliances

ed marshall

Ed Marshall

Chief Product Officer

ed marshall

Adam Hameed

President of Connected Care

Vorstand

Unserem Vorstand gehören Führungskräfte und Gründer an, die Glooko unterstützen und beraten, sodass wir weltweit führend in den Bereichen Datenmanagement und Telemedizin für Menschen mit Diabetes und chronischen Folgeerkrankungen sind

Charles Boorady

Founder & Managing Partner, Health Catalyst Capital

Simon Chong

Co-Founder and Managing Partner, Georgian Partners

Wende Hutton

General Partner, Canaan Partners

Russ Johannesson

Chief Executive Officer, Glooko

Tracy Bahl

OneOncology, CVS, General Atlantic, Emdeon, UHG

enrique

Tracy Bahl

OneOncology, CVS, General Atlantic, Emdeon, UHG

Chito Zulueta

Alfonso (Chito) Zulueta

Board Director of CTS Corp., Syneos Health, Inc., CALIDI BioTherapeutics;
Retired-President, International at Eli Lilly and Company

yogen dalal

Yogen Dalal

Founder, Glooko
Board Observer

Medizinischer Beirat

Mark Clements, M.D., Ph.D.

Glooko Chief Medical Officer, Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Pediatric Endocrinologist, Children’s Mercy Kansas City

Jerome Fischer, M.D.

Partner, Diabetes and Glandular Disease (DGD) Clinic

Michael Greenfield, M.D.

Endocrinologist, El Camino Hospital

David Kerr, M.D.

Director of Diabetes Research and Innovation, Sansum Diabetes Research Institute